Arbutus to Present AB-729 and AB-836 Data at EASL Congress
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging...
Source: globenewswire.com
Stay updated with breaking news from Oster Presentatons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging...